Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study

• Published in: Neurological sciences Vol. 33; no. Suppl 1; pp. 61 - 64
• Main Authors: Tullo, Vincenzo, Allais, Gianni, Curone, Marcella, Ferrari, Michel D., Omboni, Stefano, Benedetto, Chiara, Colombo, Bruno, Zava, Dario, Bussone, Gennaro
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 01.05.2012; Springer Nature B.V
• Subjects: Adult; Carbazoles - therapeutic use; Cross-Over Studies; Double-Blind Method; Female; Humans; Italy - epidemiology; Male; Medicine; Medicine & Public Health; Middle Aged; Migraine; Migraine with Aura - drug therapy; Migraine with Aura - epidemiology; Neurology; Neuroradiology; Neurosciences; Neurosurgery; Oxazolidinones - therapeutic use; Psychiatry; Serotonin 5-HT1 Receptor Agonists - therapeutic use; Symposium: Open Questions on Migraine; Time Factors; Treatment Outcome; Tryptamines - therapeutic use; Italy; Frovatriptan; Migraine with aura; Zolmitriptan

Migraine with aura affects ~20–30 % of migraineurs and it is much less common than migraine without aura. The aim of this study was to compare the efficacy of frovatriptan 2.5 mg and zolmitriptan 2.5 mg in the treatment of migraine with aura. Analysis was carried out in a subset of 18 subjects with...